These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 28698210)

  • 41. The DNA cytosine deaminase APOBEC3B promotes tamoxifen resistance in ER-positive breast cancer.
    Law EK; Sieuwerts AM; LaPara K; Leonard B; Starrett GJ; Molan AM; Temiz NA; Vogel RI; Meijer-van Gelder ME; Sweep FC; Span PN; Foekens JA; Martens JW; Yee D; Harris RS
    Sci Adv; 2016 Oct; 2(10):e1601737. PubMed ID: 27730215
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Transcriptional repression and apoptosis influence the effect of APOBEC3A/3B functional polymorphisms on biliary tract cancer risk.
    Liu W; Ji H; Zhao J; Song J; Zheng S; Chen L; Li P; Tan X; Ding Y; Pu R; Yin J; Han X; Cao G
    Int J Cancer; 2022 Jun; 150(11):1825-1837. PubMed ID: 35020946
    [TBL] [Abstract][Full Text] [Related]  

  • 43. DNA replication stress mediates APOBEC3 family mutagenesis in breast cancer.
    Kanu N; Cerone MA; Goh G; Zalmas LP; Bartkova J; Dietzen M; McGranahan N; Rogers R; Law EK; Gromova I; Kschischo M; Walton MI; Rossanese OW; Bartek J; Harris RS; Venkatesan S; Swanton C
    Genome Biol; 2016 Sep; 17(1):185. PubMed ID: 27634334
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DNA Deamination Is Required for Human APOBEC3A-Driven Hepatocellular Carcinoma In Vivo.
    Naumann JA; Argyris PP; Carpenter MA; Gupta HB; Chen Y; Temiz NA; Zhou Y; Durfee C; Proehl J; Koniar BL; Conticello SG; Largaespada DA; Brown WL; Aihara H; Vogel RI; Harris RS
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298259
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
    Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
    Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APOBEC3A is an oral cancer prognostic biomarker in Taiwanese carriers of an APOBEC deletion polymorphism.
    Chen TW; Lee CC; Liu H; Wu CS; Pickering CR; Huang PJ; Wang J; Chang IY; Yeh YM; Chen CD; Li HP; Luo JD; Tan BC; Chan TEH; Hsueh C; Chu LJ; Chen YT; Zhang B; Yang CY; Wu CC; Hsu CW; See LC; Tang P; Yu JS; Liao WC; Chiang WF; Rodriguez H; Myers JN; Chang KP; Chang YS
    Nat Commun; 2017 Sep; 8(1):465. PubMed ID: 28878238
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Visualization of uracils created by APOBEC3A using UdgX shows colocalization with RPA at stalled replication forks.
    Stewart JA; Schauer G; Bhagwat AS
    Nucleic Acids Res; 2020 Nov; 48(20):e118. PubMed ID: 33074285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute expression of human APOBEC3B in mice results in RNA editing and lethality.
    Alonso de la Vega A; Temiz NA; Tasakis R; Somogyi K; Salgueiro L; Zimmer E; Ramos M; Diaz-Jimenez A; Chocarro S; Fernández-Vaquero M; Stefanovska B; Reuveni E; Ben-David U; Stenzinger A; Poth T; Heikenwälder M; Papavasiliou N; Harris RS; Sotillo R
    Genome Biol; 2023 Nov; 24(1):267. PubMed ID: 38001542
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of germline variants in the APOBEC3 region with cancer risk and enrichment with APOBEC-signature mutations in tumors.
    Middlebrooks CD; Banday AR; Matsuda K; Udquim KI; Onabajo OO; Paquin A; Figueroa JD; Zhu B; Koutros S; Kubo M; Shuin T; Freedman ND; Kogevinas M; Malats N; Chanock SJ; Garcia-Closas M; Silverman DT; Rothman N; Prokunina-Olsson L
    Nat Genet; 2016 Nov; 48(11):1330-1338. PubMed ID: 27643540
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activation of DNA damage repair factors in HPV positive oropharyngeal cancers.
    Kono T; Hoover P; Poropatich K; Paunesku T; Mittal BB; Samant S; Laimins LA
    Virology; 2020 Aug; 547():27-34. PubMed ID: 32560902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. APOBEC3B is expressed in human glioma, and influences cell proliferation and temozolomide resistance.
    Schmitt C; Lucius R; Synowitz M; Held-Feindt J; Hattermann K
    Oncol Rep; 2018 Nov; 40(5):2742-2749. PubMed ID: 30226610
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The surprising activities of APOBEC3B and 5-fluorouracil.
    Walton EL
    Biomed J; 2015; 38(2):97-100. PubMed ID: 25872558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformational Switch Regulates the DNA Cytosine Deaminase Activity of Human APOBEC3B.
    Shi K; Demir Ö; Carpenter MA; Wagner J; Kurahashi K; Harris RS; Amaro RE; Aihara H
    Sci Rep; 2017 Dec; 7(1):17415. PubMed ID: 29234087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesoscale DNA Features Impact APOBEC3A and APOBEC3B Deaminase Activity and Shape Tumor Mutational Landscapes.
    Sanchez A; Ortega P; Sakhtemani R; Manjunath L; Oh S; Bournique E; Becker A; Kim K; Durfee C; Temiz NA; Chen XS; Harris RS; Lawrence MS; Buisson R
    bioRxiv; 2023 Aug; ():. PubMed ID: 37577509
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer.
    Nik-Zainal S; Wedge DC; Alexandrov LB; Petljak M; Butler AP; Bolli N; Davies HR; Knappskog S; Martin S; Papaemmanuil E; Ramakrishna M; Shlien A; Simonic I; Xue Y; Tyler-Smith C; Campbell PJ; Stratton MR
    Nat Genet; 2014 May; 46(5):487-91. PubMed ID: 24728294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differentiation signals induce
    Smith NJ; Reddin I; Policelli P; Oh S; Zainal N; Howes E; Jenkins B; Tracy I; Edmond M; Sharpe B; Amendra D; Zheng K; Egawa N; Doorbar J; Rao A; Mahadevan S; Carpenter MA; Harris RS; Ali S; Hanley C; Buisson R; King E; Thomas GJ; Fenton TR
    Res Sq; 2024 Mar; ():. PubMed ID: 38496447
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of APOBEC3A/3B germline deletion polymorphism in breast, cervical and oral cancers from South India and its impact on miRNA regulation.
    Revathidevi S; Manikandan M; Rao AK; Vinothkumar V; Arunkumar G; Rajkumar KS; Ramani R; Rajaraman R; Ajay C; Munirajan AK
    Tumour Biol; 2016 Sep; 37(9):11983-11990. PubMed ID: 27155849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of functional germline variants and a deletion polymorphism in APOBEC3A and APOBEC3B on breast cancer risk and survival in a Swedish study population.
    Göhler S; Da Silva Filho MI; Johansson R; Enquist-Olsson K; Henriksson R; Hemminki K; Lenner P; Försti A
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):273-6. PubMed ID: 26320772
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.
    Caval V; Suspène R; Shapira M; Vartanian JP; Wain-Hobson S
    Nat Commun; 2014 Oct; 5():5129. PubMed ID: 25298230
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human APOBEC3B interacts with the heterogenous nuclear ribonucleoprotein A3 in cancer cells.
    Mishra N; Reddy KS; Timilsina U; Gaur D; Gaur R
    J Cell Biochem; 2018 Aug; 119(8):6695-6703. PubMed ID: 29693745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.